The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen

The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen

Objective: Angiogenesis plays an important role in the growth and metastasis of non-small cell lung cancer (NSCLC). Bevacizumab is a humanized monoclonal antibody that mainly acts on vascular endothelial growth factor A (VEGFA) . Kinase insert domain receptor (KDR) is the most important target of VE...

Full description

Bibliographic Details
Main Authors: Nan Geng MD, Jingwei Su PhD, Zhikun Liu PhD, Cuimin Ding MD, Shaonan Xie MD, Wenxia Hu MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211019433

Internet

https://doi.org/10.1177/15330338211019433

Similar Items